Newsy's Latest Health News
Interactive Video
•
Health Sciences, Biology
•
University
•
Hard
Wayground Content
FREE Resource
The FDA has approved Adu Helm, the first Alzheimer's drug in nearly 20 years, developed by Biogen. Despite its approval, there are concerns about its effectiveness and high cost of $56,000 annually. Meanwhile, a survey reveals that 78% of vaccine-hesitant Americans are unlikely to change their stance, even as 64% of adults have received at least one COVID-19 vaccine dose.
Read more
1 questions
Show all answers
1.
OPEN ENDED QUESTION
3 mins • 1 pt
What new insight or understanding did you gain from this video?
Evaluate responses using AI:
OFF
Access all questions and much more by creating a free account
Create resources
Host any resource
Get auto-graded reports
Continue with Google
Continue with Email
Continue with Classlink
Continue with Clever
or continue with
Microsoft
%20(1).png)
Apple
Others
Already have an account?
